Vidig-M 50/500, 50/850, 5/1000mg Tablets

Therapeutic Segment: Anti-Diabetic

Generic Name: Vildagliptin

Description

Novartis’ Galvus (vildagliptin) is a member of a class of oral antidiabetic agents known as dipeptidyl peptidase IV inhibitors (DPP-IV) inhibitors or ‘incretin enhancers’.

Prescribing Information for Vidig-M

MRP: 50/500mg: 390.00 / 50/850: 450.00 / 50/1000mg: 460.00
TP: 50/500mg: 331.50 / 50/850: 382.50 / 50/1000mg: 391.00